<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00306085</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT00306085</nct_id>
  </id_info>
  <brief_title>Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis</brief_title>
  <official_title>Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Naples</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Naples</source>
  <brief_summary>
    <textblock>
      Implantation of bone marrow cells, including endothelial progenitor cells, into ischemic
      limbs has been shown to improve collateral vessel formation. In the present study the safety
      and feasibility of autologous blood mononuclear cells implantation will be investigated in
      patients with severe peripheral atherosclerosis.Twenty cases will be enrolled. Improvement in
      the ankle-brachial pressure index (ABI:&gt;0.1), ischemic ulcers and angiography as well as
      laser doppler flow will be evaluated until six months.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2005</start_date>
  <completion_date>April 2006</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical and instrumental indexes of functional impairment of peripheral atherosclerosis.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Angiographic and laser doppler measurements after six months from treatment.</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>Peripheral Vascular Diseases</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Autologous bone marrow cells</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of third or fourth class of peripheral atherosclerosis

        Exclusion Criteria:

          -  Insuline dependent diabetes

          -  Cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincenzo Sica</last_name>
    <role>Study Director</role>
    <affiliation>University of Naples</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heidi Eisele</last_name>
    <phone>+39 081/5665685</phone>
    <email>heidi.eisele@unina2.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Naples</name>
      <address>
        <city>Naples</city>
        <zip>80134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Carmela Corbisiero</last_name>
      <phone>+39081/5665681</phone>
      <email>marika_corbi@inwind.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2006</study_first_submitted>
  <study_first_submitted_qc>March 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2006</study_first_posted>
  <last_update_submitted>March 21, 2006</last_update_submitted>
  <last_update_submitted_qc>March 21, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2006</last_update_posted>
  <keyword>Peripheral arterial disease,</keyword>
  <keyword>blood marrow cells,</keyword>
  <keyword>therapeutic angiogenesis.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

